Secura Bio racks up $145 mln
Secura Bio Inc, a biopharmaceutical company focused on oncology therapies, has raised $145 million in financing. The investor was Athyrium Capital Management LP.
5 March 2019•1 min read
Secura Bio Inc, a biopharmaceutical company focused on oncology therapies, has raised $145 million in financing. The investor was Athyrium Capital Management LP.
